Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

(Reuters) - Eli Lilly's blockbuster diabetes drug Mounjaro and weight-loss therapy Zepbound, as well as Novo Nordisk's rival ...

Researchers saw significant increases in testosterone levels for men with obesity or Type 2 diabetes while taking GLP-1 medications, The Hill wrote. Also in the news: vaping, PFAS, junk food, and more ...

When people were randomised to receive either a placebo or Ozempic, they became biologically younger with the latter drug ...

The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...

GLP-1 drugs like Ozempic are transforming weight loss, but a new UVA study warns they're not improving a critical measure of ...

Supplements were also to blame when a 53-year-old woman’s left hand suddenly went numb, according to a case study in the ...

Singer songwriter Justin Timberlake is the latest in a string of famous faces to say they have been struck by tick-borne Lyme disease.

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

There's been plenty of buzz about this class of drug, following publication of a high-profile trial this year. How much do we ...